Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Sign up freePricing

Merck Global Health Innovation Fund Llc investment portfolio

Merck Global Health Innovation Fund Llc has made numerous investments in companies such as Turbine Simulated Cell Technologies, Baseimmune, and Antidote Technologies within the Biotech sector.

vc
Portfolio
3
Team
0

Portfolio (3)

CompanySectorCitySourceLast confirmed on
Antidote Technologies Ltd.
Antidote Technologies Ltd operates a digital health platform that matches patients with appropriate clinical trials, reaching millions of users across more than 180 patient communities. The service targets patients seeking trial participation and the sponsors or researchers who need to recruit participants.
Software & ITLondonConfirmed2026-06-25
Baseimmune Ltd
Baseimmune creates AI‑driven, computationally designed antigen therapeutics using advanced protein‑engineering techniques, delivering next‑generation active immunotherapies for chronic diseases. Its platform is marketed to pharmaceutical and biotech firms developing vaccines and immunotherapy
Healthcare & Life SciencesLondonConfirmed2025-10-29

Sign up to see the full portfolio

+1 more company

Sign up

Backs Similar Companies

Investors who tend to invest in the same sort of companies.

5 more similar investors hiddenSign up to unlock →

Shareholding changes (5)

Merck Global Health Innovation Fund Llc's positions across portfolio companies
2026
2025

Sign up free to see when this investor has bought or sold shares.

+3 more changes

Sign up

Articles (2)